CheckMan Stock Market Overview

Blackstone's assets under management and fee-based income rose in the third quarter. Despite that, its distributable earnings declined, leading it to pay a lower dividend this quarter.

Invesco Aerospace & Defense ETF carries a higher expense ratio than State Street SPDR S&P Aerospace & Defense ETF but has historically shown lower price volatility. State Street SPDR S&P Aerospace & Defense ETF utilizes a modified equal-weighting strategy to provide balanced exposure across various market capitalizations.

Sterling Infrastructure, Inc. STRL and EMCOR Group, Inc. EME are prominent players in the U.S. infrastructure and construction services market, benefiting from rising investments in data centers, advanced manufacturing and mission-critical facilities. Both companies are capitalizing on infrastructure modernization, expanding project pipelines and growing demand for specialized construction services.

SLB N.V. delivered robust Q3 results, with broad-based growth across segments and geographies, despite Middle East uncertainty. SLB's Digital and Data Center Solutions segments are outperforming, with double-digit growth expected in 2027 and beyond, driven by AI and modular infrastructure demand. Recent acquisitions, including Kelvion and S&P Global Energy's software portfolio, strengthen SLB's digital, thermal management, and North American offerings.

Suit alleges Anavex Life Sciences Corp. failed to disclose key facts to investors from November 26, 2025 through August 28, 2026; lead plaintiff deadline is November 30, 2026 BENSALEM TOWNSHIP, Pa., Oct. 23, 2026 /PRNewswire/ -- The Law Offices of Howard G.

Basel, 23 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today late-breaking oral presentation data from the ongoing phase III IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimised standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 - 52.0, P

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today late-breaking oral presentation data from the ongoing Phase III IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 - 52.0, P

Amerant Bancorp Inc. ( AMTB ) Q3 2026 Earnings Call October 23, 2026 9:00 AM EDT Company Participants Laura Rossi - EVP, Head of Investor Relations & Strategy Carlos Iafigliola - President, CEO & Director Sharymar Yepez - Senior EVP & CFO Conference Call Participants Michael Rose - Raymond James & Associates, Inc., Research Division Nicholas Lorenzoni - Stephens Inc., Research Division Stephen Scouten - Piper Sandler & Co., Research Division Presentation Operator Greetings, and welcome to the Amerant Third Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

Bloom Energy topped analysts' expectations for the top and bottom line in the third quarter, and the fuel-cell systems provider lifted its full-year revenue guidance. But investors are selling the stock in droves.

RMCF's second-quarter fiscal 2027 results show widening losses despite margin improvements, with liquidity concerns and strategic alternatives remaining in focus.